FMA
SGMO

FNY Managed Accounts’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

FNY Managed Accounts’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2K Sell
124
-79
-39% -$1.69K ﹤0.01% 426
2017
Q4 		$3K Buy
+203
New +$3.02K ﹤0.01% 453
2014
Q3 		– Sell
-3,500
Closed -$53.4K – 210
2014
Q2 		$53.4K Buy
+3,500
New +$50.4K 0.2% 46

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Managed Accounts's SGMO Position: Q1 2018 in Review

FNY Managed Accounts reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 39% in Q1 2018, selling an estimated $1.69K and leaving 124 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #426.

FNY Managed Accounts first reported a position in SGMO in Q2 2014 and has held it in 3 quarters since. The position peaked at $53.4K in Q2 2014. 208 funds tracked by Wall St. Rank hold SGMO as of Q1 2018.

  • FNY Managed Accounts held 124 shares of SANGAMO THERAPEUTICS INC worth $2K as of Q1 2018.
  • FNY Managed Accounts sold 79 SANGAMO THERAPEUTICS INC shares in Q1 2018, an estimated $1.69K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #426 holding.
  • FNY Managed Accounts first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and has held it in 3 quarters since.
  • FNY Managed Accounts's SANGAMO THERAPEUTICS INC position peaked at $53.4K in Q2 2014.
  • 208 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.